bioAffinity Technologies, Inc. (BIAF) Stock Overview
Explore bioAffinity Technologies, Inc.’s financial performance, market position, analyst ratings, and future outlook.
bioAffinity Technologies, Inc. (BIAF)
Key Financials
Key Financials
Market Cap
2.4M
P/E Ratio
-0.04
EPS (TTM)
$-8.52
ROE
-3.59%
BIAF Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of bioAffinity Technologies, Inc. (NASDAQ: BIAF) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, bioAffinity Technologies, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BIAF on the NASDAQ shows an RSI of 24.04, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $1.45 for the NASDAQ listing.
Key metrics behind bioAffinity Technologies, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.04 and a market capitalization of 2.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BIAF on the NASDAQ.